+86-27-65522453 sales@sun-shinechem.com


Catalog No.: 16060701
Cas No.: 737789-87-6
Purity : 98% by HPLC 
16060701 - Relugolix | CAS 737789-87-6

Catalog number : 16060701

CAS number : 737789-87-6

Molecular Formula : C29H27F2N7O5S 

Molecular Weight : 623.63 

Iupac Chemical Name : 1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-3-methoxyurea 

Smile : FC1=C(CN2C(N(C(C3=C2SC(=C3CN(C)C)C3=CC=C(C=C3)NC(=O)NOC)=O)C=3N=NC(=CC3)OC)=O)C(=CC=C1)F


PackagingPriceAvailabilityPurityEstimated Shipping Time
Request Bulk Quote Download MSDSTel:+86-27-65522453 | Email:sales@sun-shinechem.com
SynonymsRelugolix; TAK385 
Molecular FormulaC29H27F2N7O5S 
Molecular Weight623.63 
AppearanceSolid powder 
Purity98% by HPLC 
SolubilitySoluble in DMSO 
Storage-20 ºC for 3 years 
Shipping ConditionShipped under ambient temperature 
Coming soon.
 Relugolix, also known as TAK-385, is a luteinizing hormone-releasing hormone (LH-RH) receptor antagonist administered orally. By preventing LH-RH from binding with the LH-RH receptor in the anterior pituitary gland and suppressing the secretion of luteinizing hormone (LH) and follicle stimulation hormone (FSH) from the anterior pituitary gland, TAK-385 controls the effect of LH and FSH on the ovary, reduces the level of estrogen in blood, which is known to be associated with the development of endometriosis and uterine fibroids, and is expected to improve the symptoms of these disorders 

737789-87-6 - Request Bulk Quote

737789-87-6 - Request Bulk Quote